iSpecimen Inc. (ISPC) Research
iSpecimen Inc. operates a sophisticated technological platform that effectively bridges the gap between life science researchers and crucial human biological materials. Its proprietary cloud-based system empowers scientists to efficiently locate and access a vast array of biospecimens—such as biofluids, tissues, and living cells—as well as connect with potential study subjects, all sourced from a global network of healthcare providers, including hospitals, laboratories, biobanks, and blood centers. The company develops and manages iSpecimen Marketplace, an innovative online hub that strategically links medical researchers requiring access to subjects, samples, and pertinent data with organizations that hold these invaluable resources. iSpecimen's clientele primarily includes biopharmaceutical firms, in vitro diagnostics companies, and governmental and academic research institutions. The company, established in 2009, is headquartered in Lexington, Massachusetts.
Market snapshot
- Symbol
- ISPC
- Price
- $2.59
- Day change
- +1.57%
- Market cap
- $359.7K
- P/E ratio
- -0.00x
- 52-week range
- 2.5-127.2
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Next earnings
- in 2 months
Recent news
- Why iSpecimen Shares Are Surging On Friday?
iSpecimen Inc (NASDAQ: ISPC) stock is trading higher Friday after announcing a shipping overhaul that slashes transit times by up to 85%.
- iSpecimen Is Trending Overnight — Here's Why ISPC Stock Surged 56% In The After-Hours Session
iSpecimen Inc. shares surge over 56% in after-hours trading after announcing faster shipping and expanded European sourcing, despite weak fourth-quarter results.
Peer companies
Recent insider activity
- Lee Arphing — trade (0 shares) on 2025-11-07
- Liang Yuying — trade (0 shares) on 2024-12-13
- LIM ROBERT BRADLEY — trade (0 shares) on 2024-12-09
- Dhaliwal Avtar — A-Award (168 shares) on 2024-09-25
- Dhaliwal Avtar — trade (0 shares) on 2024-09-25
Open iSpecimen Inc. (ISPC) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.